Literature DB >> 31502038

Long-Non Coding RNA SNHG16 Supports Colon Cancer Cell Growth by Modulating miR-302a-3p/AKT Axis.

Dong Ke1, Qiushuang Wang1, Shaobo Ke2, Li Zou1, Qi Wang3.   

Abstract

Small nucleolar RNA host gene 16 (SNHG16) is reported to be involved in the tumorigenesis of various kinds of tumors. SNHG16 expression was reported to be upregulated in colon cancer, however, the underlying mechanism of how SNHG16 affects the colon cancer development remains poorly elucidated. In our study, with the aim to identify the role of SNHG16 on colon cell proliferation, SNHG16 was overexpressed or knocked down in vitro, respectively. SNHG16 overexpression accelerated colon cancer cell growth, while cell growth ability was impaired in SNHG16 silencing cells. Furthermore, the starBase database predicted that miR-302a-3p was the target gene of SNHG16, which was supported by dual luciferase assay. The effect of promoting cell proliferation ability induced by SNHG16 overexpression could be partly reversed by co-transfection of miR-302a-3p mimic. Application of the miRanda database indicated that AKT may be modulated by SNHG16, further evidenced by western blot and quantitative PCR assays. AKT overexpression could partly reverse the attenuated colon cancer cell growth caused by miR-302a-3p mimic transfection. Meanwhile, the combination of miR-302a-3p inhibitor and shAKT achieved the parallel result. In conclusion, our study revealed the SNHG16/miR-302a-3p/AKT axis might play a crucial role in colon cancer cell proliferation, thus participating in the process of colon cancer development.

Entities:  

Keywords:  AKT; Cell growth; Colon cancer; SNHG16; miR-302a-3p

Mesh:

Substances:

Year:  2019        PMID: 31502038     DOI: 10.1007/s12253-019-00743-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  8 in total

Review 1.  Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer.

Authors:  Zeinab Moafian; Abolfazl Maghrouni; Arash Soltani; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2021-05-31       Impact factor: 2.316

Review 2.  miRNA Clusters with Down-Regulated Expression in Human Colorectal Cancer and Their Regulation.

Authors:  Paulína Pidíkova; Richard Reis; Iveta Herichova
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

3.  Dexmedetomidine had neuroprotective effects on hippocampal neuronal cells via targeting lncRNA SHNG16 mediated microRNA-10b-5p/BDNF axis.

Authors:  Li Wang; Weihua Liu; Yanjun Zhang; Zhanfei Hu; Hao Guo; Jingshu Lv; Hongyin Du
Journal:  Mol Cell Biochem       Date:  2020-04-22       Impact factor: 3.396

Review 4.  Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer.

Authors:  Liye Wang; Kwang Bog Cho; Yan Li; Gabriel Tao; Zuoxu Xie; Bin Guo
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

5.  Ferroptosis-Related Long Noncoding RNAs as Prognostic Marker for Colon Adenocarcinoma.

Authors:  Yuting Qiu; Haobo Li; Qian Zhang; Xinwei Qiao; Jing Wu
Journal:  Appl Bionics Biomech       Date:  2022-04-08       Impact factor: 1.664

6.  Ferroptosis-Related Long Noncoding RNAs Have Excellent Predictive Ability for Multiomic Characteristics of Bladder Cancer.

Authors:  Jingchao Liu; Jingyi Cui; Shuangyi Zhao; Meng Wu; Jiawen Wang; Yaoguang Zhang; Bin Jin; Jianye Wang
Journal:  Oxid Med Cell Longev       Date:  2022-08-29       Impact factor: 7.310

7.  miR-302a-3p Promotes Radiotherapy Sensitivity of Hepatocellular Carcinoma by Regulating Cell Cycle via MCL1.

Authors:  Zifeng Yang; Menglong Zhang; Jian Zhang; Cunkun Chu; Bijuan Hu; Liyin Huang
Journal:  Comput Math Methods Med       Date:  2022-10-10       Impact factor: 2.809

8.  LncRNA SNHG16 Facilitates Nasopharyngeal Carcinoma Progression by Acting as ceRNA to Sponge miR-520a-3p and Upregulate MAPK1 Expression.

Authors:  Qingwei Wu; Yingying Zhao; Runjie Shi; Tao Wang
Journal:  Cancer Manag Res       Date:  2021-05-20       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.